Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.600
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $112.08 million as of January 2, 2026. Its market cap has increased by 48.96% in one year.
Market Cap
112.08M
Enterprise Value
-180.26K
1-Year Change
48.96%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $112.08M, a decrease of -88.15%. That is a compound annual growth rate of -31.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 112.08M | 101.26% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.78B |
| Johnson & Johnson | 499.28B |
| AbbVie | 405.42B |
| UnitedHealth Group | 302.06B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.54B |
| Novo Nordisk | 229.27B |